Dr. Reddy's Laboratories
RDY
#1789
Rank
A$16.30 B
Marketcap
A$19.53
Share price
0.43%
Change (1 day)
-9.96%
Change (1 year)

Earnings for Dr. Reddy's Laboratories (RDY)

Earnings in 2025 (TTM): A$1.34 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's current earnings are A$3.95 Billion. a decrease over its 2024 earnings that were of A$1.24 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dr. Reddy's Laboratories from 2002 to 2025

Annual earnings

Year Earnings Change
2025 A$1.21 B-2.73%
2024 A$1.24 B7.01%
2023 A$1.16 B17.62%
2022 A$0.99 B43.27%
2021 A$0.69 B31.44%
2020 A$0.52 B54.54%
2019 A$0.34 B-12.26%
2018 A$0.38 B23.6%
2017 A$0.31 B4.47%
2016 A$0.30 B-55.7%
2015 A$0.67 B1.83%
2014 A$0.66 B-3.78%
2013 A$0.69 B54.07%
2012 A$0.45 B-16.23%
2011 A$0.53 B56.66%
2010 A$0.34 B-235.36%
2009 -A$0.26 Billion-198.53%
2008 A$0.25 B30.77%
2007 A$0.19 B-14.61%
2006 A$0.23 B703.63%
2005 A$28.66 M649.45%
2004 A$3.82 M-95.68%
2003 A$88.44 M-14.86%
2002 A$0.10 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.75 B 1,772.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.18 B 1,066.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.71 B 781.57%๐Ÿ‡ซ๐Ÿ‡ท France
GSK plc
GSK
A$13.77 B 1,033.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$2.99 B 146.40%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel